Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Diagnostic Radiopharmaceuticals and Contrast Media
1.2 Key Market Segments
1.2.1 Diagnostic Radiopharmaceuticals and Contrast Media Segment by Type
1.2.2 Diagnostic Radiopharmaceuticals and Contrast Media Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Diagnostic Radiopharmaceuticals and Contrast Media Market Overview
2.1 Global Market Overview
2.1.1 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Diagnostic Radiopharmaceuticals and Contrast Media Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Diagnostic Radiopharmaceuticals and Contrast Media Market Competitive Landscape
3.1 Global Diagnostic Radiopharmaceuticals and Contrast Media Sales by Manufacturers (2019-2024)
3.2 Global Diagnostic Radiopharmaceuticals and Contrast Media Revenue Market Share by Manufacturers (2019-2024)
3.3 Diagnostic Radiopharmaceuticals and Contrast Media Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Diagnostic Radiopharmaceuticals and Contrast Media Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Diagnostic Radiopharmaceuticals and Contrast Media Sales Sites, Area Served, Product Type
3.6 Diagnostic Radiopharmaceuticals and Contrast Media Market Competitive Situation and Trends
3.6.1 Diagnostic Radiopharmaceuticals and Contrast Media Market Concentration Rate
3.6.2 Global 5 and 10 Largest Diagnostic Radiopharmaceuticals and Contrast Media Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Diagnostic Radiopharmaceuticals and Contrast Media Industry Chain Analysis
4.1 Diagnostic Radiopharmaceuticals and Contrast Media Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Diagnostic Radiopharmaceuticals and Contrast Media Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Diagnostic Radiopharmaceuticals and Contrast Media Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Diagnostic Radiopharmaceuticals and Contrast Media Sales Market Share by Type (2019-2024)
6.3 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size Market Share by Type (2019-2024)
6.4 Global Diagnostic Radiopharmaceuticals and Contrast Media Price by Type (2019-2024)
7 Diagnostic Radiopharmaceuticals and Contrast Media Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Sales by Application (2019-2024)
7.3 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size (M USD) by Application (2019-2024)
7.4 Global Diagnostic Radiopharmaceuticals and Contrast Media Sales Growth Rate by Application (2019-2024)
8 Diagnostic Radiopharmaceuticals and Contrast Media Market Segmentation by Region
8.1 Global Diagnostic Radiopharmaceuticals and Contrast Media Sales by Region
8.1.1 Global Diagnostic Radiopharmaceuticals and Contrast Media Sales by Region
8.1.2 Global Diagnostic Radiopharmaceuticals and Contrast Media Sales Market Share by Region
8.2 North America
8.2.1 North America Diagnostic Radiopharmaceuticals and Contrast Media Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Diagnostic Radiopharmaceuticals and Contrast Media Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Diagnostic Radiopharmaceuticals and Contrast Media Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Diagnostic Radiopharmaceuticals and Contrast Media Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Amag Pharmaceuticals
9.1.1 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
9.1.2 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
9.1.3 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals and Contrast Media Product Market Performance
9.1.4 Amag Pharmaceuticals Business Overview
9.1.5 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals and Contrast Media SWOT Analysis
9.1.6 Amag Pharmaceuticals Recent Developments
9.2 Bayer Healthcare
9.2.1 Bayer Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
9.2.2 Bayer Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
9.2.3 Bayer Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Product Market Performance
9.2.4 Bayer Healthcare Business Overview
9.2.5 Bayer Healthcare Diagnostic Radiopharmaceuticals and Contrast Media SWOT Analysis
9.2.6 Bayer Healthcare Recent Developments
9.3 Bracco Imaging
9.3.1 Bracco Imaging Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
9.3.2 Bracco Imaging Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
9.3.3 Bracco Imaging Diagnostic Radiopharmaceuticals and Contrast Media Product Market Performance
9.3.4 Bracco Imaging Diagnostic Radiopharmaceuticals and Contrast Media SWOT Analysis
9.3.5 Bracco Imaging Business Overview
9.3.6 Bracco Imaging Recent Developments
9.4 Daiichi Sankyo
9.4.1 Daiichi Sankyo Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
9.4.2 Daiichi Sankyo Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
9.4.3 Daiichi Sankyo Diagnostic Radiopharmaceuticals and Contrast Media Product Market Performance
9.4.4 Daiichi Sankyo Business Overview
9.4.5 Daiichi Sankyo Recent Developments
9.5 GE Healthcare
9.5.1 GE Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
9.5.2 GE Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
9.5.3 GE Healthcare Diagnostic Radiopharmaceuticals and Contrast Media Product Market Performance
9.5.4 GE Healthcare Business Overview
9.5.5 GE Healthcare Recent Developments
9.6 Guerbet
9.6.1 Guerbet Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
9.6.2 Guerbet Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
9.6.3 Guerbet Diagnostic Radiopharmaceuticals and Contrast Media Product Market Performance
9.6.4 Guerbet Business Overview
9.6.5 Guerbet Recent Developments
9.7 Lantheus
9.7.1 Lantheus Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
9.7.2 Lantheus Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
9.7.3 Lantheus Diagnostic Radiopharmaceuticals and Contrast Media Product Market Performance
9.7.4 Lantheus Business Overview
9.7.5 Lantheus Recent Developments
9.8 Mallinckrodt
9.8.1 Mallinckrodt Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
9.8.2 Mallinckrodt Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
9.8.3 Mallinckrodt Diagnostic Radiopharmaceuticals and Contrast Media Product Market Performance
9.8.4 Mallinckrodt Business Overview
9.8.5 Mallinckrodt Recent Developments
9.9 Medtronic
9.9.1 Medtronic Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
9.9.2 Medtronic Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
9.9.3 Medtronic Diagnostic Radiopharmaceuticals and Contrast Media Product Market Performance
9.9.4 Medtronic Business Overview
9.9.5 Medtronic Recent Developments
9.10 Nordion
9.10.1 Nordion Diagnostic Radiopharmaceuticals and Contrast Media Basic Information
9.10.2 Nordion Diagnostic Radiopharmaceuticals and Contrast Media Product Overview
9.10.3 Nordion Diagnostic Radiopharmaceuticals and Contrast Media Product Market Performance
9.10.4 Nordion Business Overview
9.10.5 Nordion Recent Developments
10 Diagnostic Radiopharmaceuticals and Contrast Media Market Forecast by Region
10.1 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size Forecast
10.2 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Diagnostic Radiopharmaceuticals and Contrast Media Market Size Forecast by Country
10.2.3 Asia Pacific Diagnostic Radiopharmaceuticals and Contrast Media Market Size Forecast by Region
10.2.4 South America Diagnostic Radiopharmaceuticals and Contrast Media Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Diagnostic Radiopharmaceuticals and Contrast Media by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals and Contrast Media by Type (2025-2030)
11.1.2 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Diagnostic Radiopharmaceuticals and Contrast Media by Type (2025-2030)
11.2 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Forecast by Application (2025-2030)
11.2.1 Global Diagnostic Radiopharmaceuticals and Contrast Media Sales (K Units) Forecast by Application
11.2.2 Global Diagnostic Radiopharmaceuticals and Contrast Media Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
